Baird 2015 Business Solutions Conference

Transcription

1 Baird 2015 Business Solutions Conference February worldwide

2 Forward-Looking Statement Disclaimer Statements included in this presentation that are not based on historical facts are forward-looking statements. Although such statements are based on management s current estimates and expectations, and currently available competitive, financial and economic data, forward-looking statements are inherently uncertain and you should not place undue reliance on such statements as actual results may differ materially. We caution the reader that there are a variety of risks, uncertainties and other factors that could cause actual results to differ materially from what is contained, projected or implied by our forward-looking statements. For a description of some of the risks, uncertainties and other factors that may occur that could cause actual results to differ from our forward-looking statements see our Annual Report on Form 10-K for the period ended September 26, 2014, and in particular the discussions contained in Item 1 Business, Item 1A - Risk Factors, Item 3 Legal Proceedings, and Item 7 Management s Discussion and Analysis of Financial Condition and Results of Operations, as well as the Company s other filings with the Securities and Exchange Commission. We also caution the readers of this presentation that we do not undertake to update any forward-looking statements made herein. February 2015 Slide 2

3 Jacobs Founded in 1947 Leading technical professional services firm with ~$13b revenues ~65,000 employees Significant Diversity: Clients Geographies End-markets Capabilities February 2015 Slide 3

4 Growth Strategy Differentiate with our relationship-based business model Leverage market diversity Expand geographic presence through multi-domestic strategy Strong and stable cash flows support growth investments Aggressive cost management focus February 2015 Slide 4

5 Financial Results for Q12015 From a year ago: Diluted EPS Net Earnings Backlog 8.5% 6.8% 5.8% Book-to-bill 1.08 for trailing twelve Repurchase of 2.5 million shares; total repurchases of 4.0 million shares Cash of $670.1 million; net debt of $80 million February 2015 Slide 5

6 End-Market Diversity 37% National Government 19% Chemicals 23% 46% Infrastructure 11% Oil & Gas (Upstream) 7% Revenues for twelve months ended 12/26/14: $12.8 billion PharmaBio Mining & Minerals Buildings 7% 17% 4% 7% Power, Pulp & Paper, High Tech, Food & Consumer Products Maximizing Opportunities Through Evolving Cycle 6% Refining (Downstream) 16% February 2015 Slide 6

7 Backlog Field Services Backlog ($ billions) Technical Professional Services Backlog ($ billions) February 2015 Slide 7 Q1-FY11 Q1-FY12 Q1-FY13 Q1-FY14 Q4-FY14 Q1-FY15 Professional Services Backlog a Leading Indicator

8 National Government: Steady Growth Opportunities worldwide; defense and security in US, UK, AUS and Asia US midterm elections: greater budget certainty; increasing DoD & federal civilian task orders Nuclear business overall robust; opportunities increasing in US and UK Intelligence submarket strong; gaining market share Infrastructure: Strong Public & Institutional Transport infrastructure market buoyant in US, AUS, ME, UK; steady spending growth Growing utility and water demand globally Social development policies in KSA yield opportunities; presence & relationships key Frameworks w/global commercial clients; infrastructure and building skills + global footprint Buildings: Steady Growth 7.2 Backlog (Billions) Increase in US public sector work; upsurge in DoD federal spending Strong global healthcare prospects; healthcare facility spending in GCC up 86% since 2009 Education strong globally; US bond elections; conversions Q1-13 Q1-14 Q4-14 Q1-15 Growing buildings work with non-public sector clients: headquarters, mission critical, retail February 2015 Slide 8

9 PharmaBio: Strong Client investments in India, Asia, Europe; historic strength + global footprint differentiators Standing strong amidst competitive pressures; award-winning industry leader Exciting opportunities in immunotherapy and vaccine manufacturing facilities Industrial Mining & Minerals: Stable Sustaining capital work continues to grow Studies and spending from majors beginning; Q1 stronger than expected Brownfield projects present ongoing opportunities, yet clients still cautious; mid-tiers; strong relationships Backlog (Billions) Power, Pulp & Paper, High Tech, Food & Consumer Products: Mixed Middle East power market gaining momentum; new build capacity in UK and Europe Greenfield/brownfield global opportunities: facility upgrades >$5b in US; paper machine conversions Industrial Agriculture sector in Australia/New Zealand growing; long term investment Q1-13 Q1-14 Q4-14 Q1-15 February 2015 Slide 9

10 Refining: Mixed Continued investment in North America. Europe, ME; certain projects likely delayed ISA 84 regulations drive new spending Upgrades, improvements for operating efficiency and output still strong Process Oil & Gas: Weak Brownfield & enhanced recovery work still economical; some greenfield delays/cancellations Shift to high ROI basins in US; clients seeking new onshore & offshore capacity; footprint key Sustaining capital work continues to be stable Backlog (Billions) Chemicals: Strong Broadly, chemical investment remains strong globally; pure chemical companies benefit Large energy clients experience ROI hurdles for certain projects Strong chemical resume plus global delivery are key strengths Q1-13 Q1-14 Q4-14 Q1-15 February 2015 Slide 10

11 Geographic Diversity February 2015 Slide 11

12 National Government Chemicals PharmaBio Food & Consumer Products Buildings Oil & Gas Upstream Mining & Minerals High Tech Infrastructure Refining Downstream Power Pulp & Paper February 2015 Slide 12

13 Copyright 2015 Jacobs Engineering Group Inc. All rights reserved. Jacobs and BeyondZero are trademarks of Jacobs Engineering Group Inc. CC 01/15 worldwide